The WWP1 downregulation was found to induce autophagy activation which, in turn, suppresses the growth and proliferation of AML blasts and delays leukemia progression in mice bearing AML cancer (Sanarico et al. 2018), showing that WWP1 inhibition can be a valuable therapeutic approach for AML cancer. The gene discussed is WWP1; the disease is leukemia.